(Q39778756)

14 September 2017

Molecular diagnosis of Borrelia bacteria for the diagnosis of Lyme disease (English)

1 reference

14 September 2017

0 references

1

Alje P van Dam

0 references

author name string

Alje P van Dam

series ordinal

1

1 reference

PubMed ID

23480587

14 September 2017

language of work or name

English

0 references

publication date

8 February 2011

1 reference

Expert Opinion on Medical Diagnostics

14 September 2017

1 reference

14 September 2017

5

1 reference

14 September 2017

2

1 reference

14 September 2017

135-149

1 reference

Diagnosis of lyme borreliosis

14 September 2017

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Multilocus sequence analysis of Borrelia bissettii strains from North America reveals a new Borrelia species, Borrelia kurtenbachii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

A new Borrelia species defined by multilocus sequence analysis of housekeeping genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Clinical findings for patients with Lyme borreliosis caused by Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities to strain 25015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Lyme borreliosis in Portugal caused by Borrelia lusitaniae? Clinical report on the first patient with a positive skin isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

An epidemiologic study of Lyme disease in southern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Comparison of PCR methods and culture for the detection of Borrelia spp. in patients with erythema migrans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Prospective study of serologic tests for lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Seronegative Lyme arthritis caused by Borrelia garinii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Seronegative chronic relapsing neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Subjective symptoms after treatment of early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Importance of sample preparation for molecular diagnosis of lyme borreliosis from urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Linear- and circular-plasmid copy numbers in Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

PCR in lyme neuroborreliosis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Diagnostic utility of Borrelia burgdorferi cerebrospinal fluid polymerase chain reaction in children with Lyme meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Improvement in the laboratory recognition of lyme borreliosis with the combination of culture and PCR methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Lyme meningoradiculitis: prospective evaluation of biological diagnosis methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Course of Borrelia burgdorferi DNA shedding in urine after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Final report of the Lyme disease review panel of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Prevalence and diversity of Borrelia species in ticks that have bitten humans in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

Three Major Lyme Borrelia Genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) Identified by PCR in Cerebrospinal Fluid from Patients with Neuroborreliosis in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2011.555396

10.1517/17530059.2011.555396

21 January 2018

Identifiers

DOI

1 reference

release_yu56oun7izg45fkxkdyy6y7pji

14 September 2017

0 references

PubMed ID

23480587

1 reference

PubMed ID

23480587